Drugs / UCB-Treg
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT03011021 | Jan 2017 → Jun 2025 | type 1 diabetes mellitus | Second Xiangya Hospital of Central South University | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | UCB-Treg | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03011021 ↗ |
| Modality | Cell therapy | “ex-vivo expanded umbilical cord blood regulatory T cells” NCT03011021 ↗ |